Atlas Trials

Efficacy of a 14-Day Bismuth-Containing Quadruple Therapy Guided by Drug Susceptibility Testing in Patients with Extremely Refractory Helicobacter Pylori Infection: an Exploratory Study

Clinical trial NCT06731023 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06731023
Sponsor
Xiuli Zuo
Status
NOT_YET_RECRUITING
Study type
OBSERVATIONAL
HELICOBACTER PYLORI INFECTIONS
Start date
2025-01-01
Primary completion
2026-12-31
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.